Oncology News, Insights, Stories by OncoDaily

Breaking Barriers: Strengthening Early Childhood Cancer Diagnosis in Ghana and South Africa
2025-11-25 | Shinjuku
The webinar, “Breaking Barriers: Strengthening Early Childhood Cancer Diagnosis in Ghana and South Africa,” is a vital session hosted by World Child Cancer and CHOC Childhood Cancer Foundation SA as part of London Global Cancer Week. Scheduled for November 25, 2025, at 12:00 PM GMT, the event will highlight the progress and challenges in early childhood cancer diagnosis, which remains a significant hurdle in pediatric oncology.
Attendees will hear from experts, including Ayire Adongo and Luke Capper from World Child Cancer and Adri Ludick from CHOC, on what effective strategies are driving change in these African nations and outlining the next steps required to improve outcomes for children with cancer.
Register.

APODDC vMTB No. 2 - Strategies for Genitorurinary Treatment
2025-11-26 | Shinjuku
The Asia-Pacific Oncology Drug Development Consortium (APODDC) is hosting its 2nd Virtual Molecular Tumour Board (vMTB). This complimentary, specialized webinar is scheduled for Wednesday, November 26, 2025, running from 4:00 PM to 5:15 PM (GMT+8). The session is highly relevant for professionals across the region interested in cutting-edge oncology practices.
The second session of the vMTB will be hosted by executive member Prof. Toshio Shimizu, and will feature expert insights from Dr. Tahlia Scheinberg and A/Prof. Ben Tran. The speakers will concentrate on practical profiling strategies and treatment planning used within the field of genitourinary cancers, specifically using detailed bladder and prostate cancer case studies to illustrate their points.
Register,

ESMO Guidelines: Real World Cases - Webinar Series: Lymphoma 2025
2025-11-26 | https://oncodaily.com/event/413052
The ESMO Guidelines: Real World Cases – Webinar Series: Lymphoma 2025 will be held live on 26 November 2025 at 18:30 CET.
This webinar applies the latest ESMO Clinical Practice Guidelines to real-world lymphoma cases. Participants will gain insights into evidence-based management, innovative therapies, and practical strategies for Hodgkin and non-Hodgkin lymphomas, earning 1 ESMO-MORA category 1 point and a certificate of attendance.

3rd AICRIstart Symposium
2025-11-26 - 2025-11-27 | UCD Conway Institute of Biomolecular and Biomedical Research / Conway Lecture Theatre, University College Dublin, Belfield, Dublin, Dublin, Dublin 4, Ireland
The 3rd AICRIstart Symposium is a two-day, in-person event dedicated to developing the next generation of cancer researchers within the All-Island Cancer Research Institute (AICRI) collaborative framework. Scheduled for November 26th and 27th, 2025, the symposium will be held at the Conway Lecture Theatre, Conway Institute, UCD (University College Dublin).
The event’s educational focus is on showcasing cancer research and collaboration across the island of Ireland, featuring presentations from AICRIstart PhD students and postdoctoral fellows on topics including immunotherapy, biomarker discovery, and next-generation diagnostics.
A key highlight will be the Keynote Address delivered by Prof. John Crown, alongside a Panel on Career Pathways featuring experts from diverse sectors such as hospitals, industry (Roche Ireland, Tangram Therapeutics), advocacy (Irish Cancer Society), and academia.
Agenda.
Register.

22nd National Oncology Congress, Portugal
2025-11-26 - 2025-11-28 | Forum Braga, Av. Dr. Francisco Pires Gonçalves, Braga, 4715-558, Portugal
The 22nd National Oncology Congress (CNO25), organized by the Portuguese Society of Oncology (SPO), will be held from Wednesday, November 26, to Friday, November 28, 2025, at the Forum Braga in Braga, Portugal.
Operating under the challenging theme “Beyond Limits” (Superar Barreiras, Transformar a Oncologia), the congress is a major national event in the field, serving as a call to action for the oncology community to constantly overcome the scientific, clinical, social, and human barriers in the fight against cancer, while offering a venue to reflect, share knowledge, and promote research in the country.

The Secondary Use of Health Data, Digital Twins to Improve Clinical Trials
2025-11-26 18:00 - 19:00 (America/Halifax) | Shinjuku
Digital health and artificial intelligence are reshaping the landscape of clinical care and patient engagement. This session will examine how these technologies are advancing decision-making, enabling more personalized treatment, and enhancing the overall patient experience. Leading experts will offer their insights on current innovations and future developments in this rapidly evolving field.

18.00 – CET Introduction – Antonio Marra, IT
18.05 – CET Harnessing real-world data and digital twins to enhance oncology clinical trials – Arsela Prelaj, IT
18.25 – CET Regulatory and ethical pathways for the secondary use of health data in the EU – Mélodie Bernaux, BE
18.45 – CET Discussion and Q&A
18.55 – CET Closing remarks – Antonio Marra, IT

This session is part of the SPCC Sustaining Corporate Programme 2025.
Sharing Progress in Cancer Care wishes to extend appreciation to its Sustaining Companies for providing unrestricted educational support to the following webinar. Companies have no control over the session content or speakers.

You can find more posts featuring SPCC on OncoDaily.

VI Unified Congress of the Russian Society of Pediatric Oncologists and Hematologists (RODOG)
2025-11-27 - 2025-11-29 | AZIMUT City Hotel Olympic Moscow, Olimpiysky Prospekt 18/1, Moscow, Moscow Oblast, 129110, Russian Federation
The VI Unified Congress of the Russian Society of Pediatric Oncologists and Hematologists (RODOG): Current Issues and Development Prospects for Pediatric Oncology and Hematology in the Russian Federation is a major, three-day Russian congress on pediatric oncology and hematology.
It will take place from November 27 to 29, 2025, with the aim of discussing current issues and future development prospects in the field across the Russian Federation. The event is hosted in a hybrid format, allowing participants to attend in person at the AZIMUT Olympic Hotel (Olimpiysky Prospekt, d. 18/k1) in Moscow, or virtually via the dedicated website.https://azimuthotels.com/en/moscow/azimut-hotel-olympic
Read further.

Global Strategies to Reverse the Rise of Liver Cancer
2025-11-27 | Shinjuku
The free webinar, “Global strategies to reverse the rise of liver cancer,” hosted by The Lancet Webinars in partnership with London Global Cancer Week, will be held virtually on Thursday, November 27, 2025, at 09:00 London (GMT +0:00).
The session aims to foster a global dialogue among healthcare professionals, researchers, and policymakers to address the worldwide increase in liver cancer, which is projected to nearly double its case numbers by 2050.
Key topics covered will include comprehensive strategies from The Lancet Commission on addressing the global hepatocellular carcinoma (HCC) burden, regional differences in cancer management, and the emerging threat of metabolic dysfunction-associated steatotic liver diseases (MASH). Expert speakers include Helena Wang and Vania Wisdom from The Lancet, and professors Jian Zhou, Stephen Lam Chan, Jordi Bruix, and Hongmei Zeng.

UpToDate 6.0 + ESMO
2025-11-27 - 2025-11-28 | Ramada Encore by Wyndham Kyiv, 103, Stolychne Highway, Kyiv, Kyiv Oblast, 03131, Ukraine
The UpToDate 6.0 + ESMO conference, organized by the Ukrainian Society of Clinical Oncologists (USCO) in partnership with ESMO, is a two-day event scheduled for November 27–28, 2025.
This major oncology conference will be held in Kyiv, Ukraine, at the Ramada Encore Kyiv. The primary goal is to bring together a multidisciplinary community of experts—including medical oncologists, surgeons, and pathologists—for the sixth consecutive year to share the latest and most innovative ideas in cancer diagnosis and treatment, with all participants receiving Continuing Medical Education (CME) points.
Register.

Best of WCLC 2025 Hungary
2025-11-27 - 2025-11-29 | Danubius Hotel Helia, Kárpát u. 62-64, Budapest, 1133, Hungary
The Best of WCLC 2025 Hungary is integrated into the 21st Central European Lung Cancer Conference (CELCC 2025), taking place from November 27–29, 2025, at the Danubius Hotel Helia in Budapest, Hungary.
This combined event serves as a vital platform for Central Europe, offering the most important highlights from the World Conference on Lung Cancer (WCLC) alongside a comprehensive program covering the full spectrum of lung cancer, including basic research, updated clinical guidelines, and real-world practice, all aimed at strengthening regional collaboration and knowledge exchange.

The Role of Surgery in Metastatic NET
2025-11-27 17:00 - 18:00
The European Society of Surgical Oncology (ESSO) is hosting a free webinar titled “The Role of Surgery in Metastatic NET (Neuroendocrine Tumors)“ on Wednesday, November 27, 2025, from 17:00 to 18:00 CET.
The webinar aims to educate surgical oncologists, senior residents, medical oncologists, and other professionals involved in NET care on the current role, selection criteria, and timing of surgical intervention within a multidisciplinary strategy.
Key topics covered will include defining surgical selection criteria for metastatic NETs, discussing the interplay between debulking surgery and radioligand therapy, and reviewing the indications and outcomes of liver transplantation for NET metastases in the modern therapeutic landscape. The session will feature presentations from speakers Ruben Bellotti and Emilio Bertani, and will be moderated by Stefan Stättner and Stefano Partelli.
Register.

ESMO Advanced Course on ADC Development, Therapeutic Applications and Research in GI and Gynaecological Cancers 2025: Zurich
2025-11-28 - 2025-11-29 | Dorint Airport-Hotel Zurich, Riethofstrasse 40,, 8152 Opfikon, Zurich
The ESMO Advanced Course on ADC Development, Therapeutic Applications and Research in Gastrointestinal and Gynaecological Cancers 2025: Zurich is a two-day educational event organized by ESMO (European Society for Medical Oncology).
Scheduled for November 28–29, 2025, in Zurich, Switzerland, the course is focused on providing in-depth insights into Antibody-Drug Conjugates (ADCs), including their development, mechanism of action, integration into current clinical guidelines, and management of associated toxicities. The program is accredited with 10 ESMO-MORA category 1 points for Continuing Medical Education.

Best of ESMO 2025 Breast Cancer China Session
2025-11-29
The Best of ESMO 2025 Breast Cancer China Session is an ESMO Licensed Event scheduled as a virtual session on November 29, 2025, at 12:00 CET.
This event is designed to efficiently disseminate the most practice-changing and relevant scientific findings in breast cancer from the main ESMO Congress 2025 to healthcare professionals in the region. The content is accessible online and is presented in both Chinese (Traditional) and English.

Best of MASCC India 2025
2025-11-29 09:00 - 18:00 | Fairfield by Marriott, Mumbai, Maharashtra, India, Samitha Industrial Estate, Plot No. 16-B, Andheri - Kurla Rd, Saki Naka, Mumbai, Maharashtra, 400072, India
The Best of MASCC 2025 – 7th Annual Meeting of Supportive Care in Cancer is a one-day conference focused on advances in supportive care for cancer patients.
Organized by the Integrated Association of Supportive Care in Cancer (IASCC) in collaboration with MASCC and the Nag Foundation, the event is scheduled for Saturday, November 29th, 2025, running from 9:00 AM to 6:00 PM.
The conference will be held in-person at the Fairfield by Marriott, Mumbai, and operates under the theme: “Advancing Supportive Cancer Care: Evidence, Innovation and Compassion.” The program is designed to bring together clinicians, researchers, and professionals to highlight key takeaways from the international MASCC 2025 meeting and showcase current research and innovative supportive care practices within India.
Register.

SIOP Nursing News Meeting
2025-12-01
The SIOP Nursing News Meeting is a virtual event organized by the International Society of Paediatric Oncology (SIOP) to facilitate alignment and collaboration within the SIOP Nursing Network.
Scheduled for Monday, December 1, 2025, at 3 PM CET (Central European Time) via Zoom, the primary objective of this meeting is to share progress highlights, key outputs, and next steps from the various SIOP Nursing groups, ensuring members stay informed and can identify opportunities to work together on common goals.
Register.

Cancer Cell Plasticity: Cracking the Code of Adaptation and Survival
2025-12-02 - 2025-12-03 | Shinjuku
The conference “Cancer Cell Plasticity: Cracking the Code of Adaptation and Survival,” organized by the European Association for Cancer Research (EACR), is a Virtual Event scheduled for December 2-3, 2025. The educational focus is on the fundamental mechanisms that control cancer cell plasticity—the ability of cancer cells to change their phenotype, function, and behavior to adapt and survive.
Experts will discuss non-genetic mechanisms (like epigenetic modifications and metabolic reprogramming) that drive tumour heterogeneity, metastasis, and therapeutic resistance, with the ultimate goal of advancing knowledge to develop innovative therapeutic strategies to prevent or reverse the adaptive prowess of cancer cells.

Hack4Hope 2025: 2nd Edition
2025-12-03 | Futur4care, Watt-Biopark, 8 Rue Jean Antoine de Baïf, 75013
Hack4Hope 2025, taking place on December 3 at Futur4care, Watt-Biopark in Paris, is organized by the Paris-Saclay Cancer Cluster (PSCC) and its Childhood Cancer Working Group. Building on the success of the first edition, this event aims to improve the treatment outcomes of childhood cancer. The event will bring together experts from diverse fields, including clinicians, researchers, industry leaders, AI and machine learning experts, entrepreneurs, and patient representatives, fostering collaboration to make significant progress in childhood cancer care.
Participants can join either as competing projects, with access to expert mentorship, resources, and financial prizes, or as attendees to hear presentations, witness innovative solutions, and network with key stakeholders. Hack4Hope 2025 offers an opportunity to contribute to revolutionary advancements in pediatric oncology and to be part of a community dedicated to offering a brighter future for children with cancer and their families. Registration is open for both candidates and attendees, with remote participation available.

ESMO Guidelines: Real World Cases - Webinar Series: Prostate Cancer 2025
2025-12-03
The ESMO Guidelines: Real World Cases – Prostate Cancer 2025 is a one-hour live virtual webinar held by the European Society for Medical Oncology (ESMO) on December 3, 2025, at 18:30 CET. Its goal is to disseminate and critically review the updated ESMO Clinical Practice Guidelines for prostate cancer by applying them to a detailed, real-world clinical case, focusing on optimal treatment sequencing and the integration of novel therapies.
The session is targeted at all healthcare professionals working in Oncology, and live viewers will be awarded a certificate of attendance and 1 ESMO-MORA category 1 point.
Register.

Psychosocial Standards of Cancer Care from AHOPCA Region
2025-12-03
The webinar “Psychosocial Standards of Cancer Care from AHOPCA Region“ is an educational, online session focused on pediatric oncology. Scheduled for Wednesday, December 3, 2025, at 3 PM CET (Central European Time) via Zoom, the webinar will be presented by speaker Ana Cáceres Serrano, PhD, a Guatemalan psycho-oncologist.
The session aims to teach participants the process carried out by the psychosocial teams in the AHOPCA region (Pediatric Hemato-Oncology Association of Central America) to establish their own standards for psychosocial care. The AHOPCA region includes Guatemala, El Salvador, Honduras, Nicaragua, Costa Rica, the Dominican Republic, and Haiti.
Register.

CancerWISE - CJC AFRICA Cervical Cancer Virtual Tumor Board
2025-12-03
The CJC AFRICA Cervical Cancer Virtual Tumor Board will hold its next CancerWISE session, dedicated to the management of Metastatic Cervical Cancer, on Wednesday, December 3, 2025, at 19:00 Cairo Time via Zoom.
Organized by the CAIRO Journal Club, this free educational virtual tumor board is designed for healthcare professionals (HCPs) across Africa and is supported by an educational grant from MSD Africa. Registration is mandatory to attend this session, which focuses on advancing knowledge in cervical cancer care.
Register.

ESMO Preceptorship on Gastric Cancer 2025: Singapore
2025-12-03 - 2025-12-04 | Singapore, Republic of Singapore
The ESMO Preceptorship on Gastric Cancer 2025: Singapore is an intensive two-day educational event focused on the multidisciplinary management of gastric and gastro-esophageal junction (GEJ) cancers.
Scheduled for December 3–4, 2025, in Singapore, Republic of Singapore, the program is designed to cover topics ranging from the fundamentals of epidemiology and molecular factors to best clinical practices in surgical, adjuvant, and metastatic settings. The course aims to teach participants to compare various approaches, manage special situations and side effects, and learn about novel treatment targets. This event is accredited with 9 ESMO-MORA category 1 points.

ESMO Preceptorship on Breast Cancer 2025: Singapore
2025-12-03 - 2025-12-04 | Singapore, Republic of Singapore
The ESMO Preceptorship on Breast Cancer 2025: Singapore is a two-day educational event focused on various aspects of breast cancer management, co-chaired by Rebecca Dent and Matteo Lambertini.
Scheduled for December 3–4, 2025, in Singapore, Republic of Singapore, the program aims to provide comprehensive learning on screening, diagnosis, genetic testing, the biology of the disease, and the crucial role of multidisciplinary care in managing early, locally advanced, and metastatic breast cancer across surgical, radiation, and systemic therapy settings. The course is accredited with 10 ESMO-MORA category 1 points

65th Annual Meeting of the Italian Cancer Society Targeting Cancer Hallmarks
2025-12-03 - 2025-12-05 | Grattacielo Intesa Sanpaolo, Corso Inghilterra, 3, Turin, Piedmont, 10138, Italy
The 65th Annual Meeting of the Italian Cancer Society (SIC), themed “Targeting Cancer Hallmarks,” is scheduled to take place from 3-5 December in Turin, Italy, at the Grattacielo Intesa Sanpaolo. The conference will address the core biological capabilities that enable cancer cells to survive and proliferate, focusing on the latest strategies for targeting these hallmarks through cutting-edge technologies and artificial intelligence. Organized by Scientific Coordinators Maurizio D’Incalci and Federica Di Nicolantonio, the meeting is designed for a broad audience, including basic, pre-clinical, translational, and clinical researchers, with abstract submissions open until Saturday, 20 September 2025.

6th CRC Screening Summit
2025-12-04 | Shinjuku
The 6th Colorectal Cancer (CRC) Screening Summit, hosted by Digestive Cancers Europe (DiCE), is an online event scheduled for December 4, 2025, from 9:00 AM to 12:30 PM CET. The summit will build upon previous discussions regarding the urgent challenge of early detection and prevention of colorectal cancer, a leading cause of cancer deaths in Europe.
The goal is to collaborate with experts, healthcare professionals, and policymakers to advance effective, accessible, and sustainable screening programs across the continent, driving progress toward better prevention, earlier diagnosis, and improved health outcomes for all European communities.
Register.

Anti-HER2 Therapies: Biological Mechanisms and Toxicity Management
2025-12-04 | Shinjuku
The event “Anti-HER2 therapies: biological mechanisms and toxicity management“ is a live webinar scheduled for December 4, 2025, at 18:00 CET.
This online educational session is focused on breast cancer and will feature experts who will discuss the molecular mechanisms that underpin HER2-targeted treatments and their role in improving patient outcomes, while also providing a comprehensive and practical overview of the challenges and strategies for managing therapy-related toxicities.
The webinar aims to enhance the knowledge of clinicians and researchers involved in the care of patients with HER2-positive breast cancer.

Pediatric Cardio-Oncology Consortium Virtual Summit
2025-12-04 | Shinjuku
The Pediatric Cardio-Oncology Consortium (PCOC) Virtual Summit is a complimentary, CME-accredited online event scheduled for December 4, 2025, 10 AM EST, and is jointly sponsored by Cincinnati Children’s Hospital Medical Center, Sofia’s Hope, and the Pediatric Cardiomyopathy Registry, in conjunction with the International Cardio-Oncology Society.
The summit’s goal is to bring together a multidisciplinary group of healthcare professionals to discuss and shape the optimal management of pediatric cardio-oncology. The program is focused on three main sessions: Multi-Modality Imaging Surveillance in pediatric cardio-oncology, Cardiovascular Toxicity in Pediatric Oncology (covering new agents like Tyrosine Kinase Inhibitors and Immunotherapies), and addressing Cardiovascular Disease in Young Adult Survivors.
Register.

7th European Cancer Forum
2025-12-04 | Residence Palace, Brussels, Rue de la Loi 155, Bruxelles (Brussels), Region of Brussels-Capital, 1040, Belgium
The 7th edition of the European Cancer Forum (ECF) on December 4, 2025, will be held under the theme “Innovation, Security and Sustainability: Shaping the Future of Cancer Care,” aiming to ensure that advancements in oncology are not sidelined by the EU’s focus on external challenges.
This high-level policy forum will gather leading policymakers, healthcare professionals, industry experts, and patient advocates to reflect on progress under Europe’s Beating Cancer Plan and strategically align the future of cancer care with the European Union’s broader ambitions for health security, innovation, and long-term sustainable healthcare systems.
Register.

How to Make Sense of Treatment Options for Hepatocellular Carcinoma in 2025
2025-12-04
The OncoWisdom Webinar titled, “How to Make Sense of Treatment Options for Hepatocellular Carcinoma in 2025,” is a free session for oncologists, surgeons, hepatologists, and researchers focusing on liver cancer care. The live, online event is scheduled for December 4, 2025, starting at 6:30 PM IST (Indian Standard Time).
The agenda includes an opening session on Integrating local and systemic therapy in HCC, followed by a panel discussion on current and emerging data, all part of OncoWisdom’s mission to facilitate evidence-based discussions among global experts to elevate cancer care worldwide.
Register.

Exploring the Tumour Immune Landscape: Spatial and Functional Insights
2025-12-04 15:00 - 16:00 | Shinjuku
The “Exploring the tumour immune landscape: Spatial and functional insights” EACR and 10x Genomics Webinar is a free, virtual event scheduled for December 4, 2025, from 15:00 to 16:00 CET on Zoom.
This educational collaboration between the European Association for Cancer Research (EACR) and 10x Genomics focuses on using advanced technologies to understand the tumor immune microenvironment. The webinar will feature two expert speakers discussing research on spatially resolving antigen receptors in tumor tissue, and the ex vivo modeling of the tumor immune microenvironment in lung cancer to investigate responses to therapies and immune evasion mechanisms.
Register.

Gustave Roussy and Friends Invite 2025
2025-12-05 | Espace Congrès les Esselières, 3 Boulevard Chastenet de Géry, Villejuif, Val-de-Marne, 94800, France
The Gustave Roussy and Friends Invite 2025: Connecting institutions, sharing visions, transforming cancer care will hold its second edition on December 3, 2025, in Paris. The annual event is a dynamic platform for collaboration, bringing together oncological teams and their medical ecosystems to exchange insights on the evolving landscape of cancer treatment and patient care. This edition will honor the German Cancer Research Center (DKFZ) and the National Center for Tumor Diseases (NCT) Heidelberg as distinguished guests, with lectures and discussions focusing on critical topics such as institutional transformation, healthcare organization, research, access to innovative therapies, and the essential role of patient representation.
